Key facts
- This page summarizes Robert Auciaux's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 May 2022, 17:11.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Section 16 status
Robert Auciaux is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted.
Footnote F2
The reporting person's service on the issuer's Board of Directors terminated on February 9, 2022. Per the individual's equity grant agreements, the issuer is distributing shares of common stock equal to the number of DSU's previously granted to the reporting person.